ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Texas Voters Approve $3 Billion In Bonds For Cancer Research.

November 9, 2007

NCI Would Get More Money For AIDs Under Heckler Proposal, But Most Would Come Out Of Construction

August 2, 1985

Funding opportunities listed.

January 16, 2004

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008

Long-term Hormonal Therapy Adds No Additional Benefits

September 27, 2013